Fundraising FoxCONKA
1 known investors
Find your way into CONKA
Sign up to see every warm intro you have to CONKA
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CONKA team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CONKA makes a patented, caffeine-free nootropic shot system (Flow for mornings, Clear for afternoons) combining nootropics and adaptogens to support focus, memory, and mental endurance, backed by clinical trials and university research. It pairs the supplement with a free app containing a Cambridge-derived, NHS-validated cognitive test so users can track changes in their own brain performance, and is marketed to athletes, entrepreneurs, and professionals in the UK.
Investors · 1
Companies House · registry record
View on Companies House ↗- Registered name
- CONKA LTD
- Company number
- 08423257
- Status
- Dissolved
- Company type
- Private limited company
- Incorporated
- 28 Feb 2013
- Dissolved
- 24 Jan 2023
- Registered office
- 703 Phoenix Heights East 4 Mastmaker Road, London, E14 9AJ
- Nature of business (SIC)
- 46480 — Wholesale of watches and jewellery74100 — specialised design activities
- Accounts
- last made up to 28 Feb 2022
Current officers
- Shangming Cai — director, appointed 28 Feb 2013
Source: Companies House public register · retrieved 4 Oct 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does CONKA do?
- CONKA makes a patented, caffeine-free nootropic shot system (Flow for mornings, Clear for afternoons) combining nootropics and adaptogens to support focus, memory, and mental endurance, backed by clinical trials and university research. It pairs the supplement with a free app containing a Cambridge-derived, NHS-validated cognitive test so users can track changes in their own brain performance, and is marketed to athletes, entrepreneurs, and professionals in the UK.
- Who are CONKA's investors?
- CONKA's investors include Cliff Capital.